Skip to content

Multiple Myeloma Treatment Response Levels: CR, VGPR, PR and More

Release Date: 11 Mar 2025 Patient Power
College of American Pathologists Logo

CAP Members Megan O Nakashima, MD, FCAP, and Adam Cloe, MD, FCAP, discuss multiple myeloma treatment. "One advantage of immunofixation is it can detect even very small quantities of abnormal immunoglobulin, and so it can be very sensitive to detect relapse," Dr. Cloe said.

For the full article click here: Multiple Myeloma Treatment Response Levels: CR, VGPR, PR and More

adding all to cart
False 0
File added to media cart.